/
/
/

Supha Pharmachem Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2025Jun 2025Mar 2025
₹111 Cr₹113 Cr₹264 Cr
₹3 Cr₹3 Cr₹66 L
₹114 Cr₹117 Cr₹265 Cr
₹104 Cr₹111 Cr₹265 Cr
₹11 Cr₹5 Cr₹20 L
₹19 L-₹37 L₹2 Cr
₹10 Cr₹6 Cr-₹1 Cr
₹9 Cr₹5 Cr-₹2 Cr

Share Price Live Stats

Open (₹)0.28
Volume (₹)31.96 L
High (₹)0.28
Upper Circuit0.29
Low (₹)0.27
Lower Circuit0.27
Prev Close0.28
52W High (₹)1.80
Price0.27
52W Low (₹)0.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)24.70 Cr
Div. Yield (%)0.00
PE Ratio11.60
Debt to Equity26.01
Price to Book1.67
Book Value0.76
EPS (TTM)0.02
Face Value1.00
ROE (%)4.85

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
PREMIERENE-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
SUPHA-ZNSE
LTP
1W Low
1W High
Market cap (₹)
2936-230 (-7.26%)
2831.65
3168
3,90,684Cr
998-16 (-1.58%)
995.50
1028.55
45,486Cr
1270.55-19.05 (-1.48%)
1180.45
1327.30
45,144Cr
3722.05+145.1 (4.06%)
3458.85
3796.35
44,346Cr
371.4+5.55 (1.52%)
343.80
378.95
29,113Cr
476.5+5.75 (1.22%)
465.25
494
15,566Cr
74+0.86 (1.18%)
69.53
74.50
10,984Cr
342.6-8.4 (-2.39%)
340.10
357.45
7,747Cr
518.95+7 (1.37%)
497.75
529.80
6,238Cr
114.2-0.8 (-0.70%)
110.60
116.95
572Cr
0.27-0.03 (-10.00%)
0.27
0.30
25Cr

Key Highlights of Supha Pharmachem Ltd’s P&L

Depreciation was ₹3.87Lakh and finance costs were ₹7.64Cr in 2025-03-31